Gynecologic Cancer News

One of every four patients with a gynecologic oncology office visit had inadequate levels of cancer health literacy, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Dostarlimab plus carboplatin significantly increased PFS among women with primary advanced or recurrent endometrial cancer, according to study results presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

The addition of pembrolizumab to chemotherapy significantly extended PFS for women with advanced or recurrent endometrial cancer, according to study results presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

A digital tool that tracks patient-reported symptoms helped identify post-discharge complications among women with gynecologic cancer who underwent debulking surgery, according to retrospective study results.

Niraparib did not significantly extend OS among women with recurrent ovarian cancer, according to long-term follow-up results of the ENGOT-OV16/NOVA trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Neoadjuvant therapy with olaparib showed feasibility for women with germline-mutant ovarian cancer, according to results of the NOW trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

The addition of nab-paclitaxel to cisplatin-based concurrent chemoradiotherapy appeared effective for women with locally advanced cervical cancer, according to prospective study results.

A review of established associations between cancer waiting times and treatment outcomes has identified discrepancies in the measurement and reporting of lag times between diagnosis and treatment.

Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.

The concept of cancer vaccination has generated excitement in the scientific community for decades.